Vectura Group (VEC)

Sector: Pharma and Biotech     Index: FTSE 250
0.38%
0.35p
92.15p
10:50 22/11/17
92.15p
10:50 22/11/17
DAILY VARIATION
0.38%
0.35p
VOLUME
116,862
REAL TIME BATS
92.35p
11:09 22/11/17
0.60%
0.55p
DATA
52 Week High
163.00p
52 Week Low
89.95p
Shares Issued
678.93m
Market Cap
£625.63m
RiskGrade
170
Beta
0.36
MENU

Vectura Group Overview

Vectura develops inhaled therapies principally for the treatment of respiratory diseases.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -35.2% -51.9%
ROCE 0.0%
Latest F'cast
P/E 12.4 31.4
PEG 0.4 -0.5
Pr/Revenue 3.7 4.1
Pr/Book 0.9
Latest F'cast
Revenue 133.2% -28.0%
PBT 0.0% n/a
EPS 30.4% -52.4%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2013-03-31 30.50 -10.40 -1.80p -50.4 0.0 n/a n/a 0.0%
2014-03-31 36.50 -4.80 1.50p 102.2 0.0 n/a n/a 0.0%
2015-03-31 58.00 -6.20 4.00p 36.4 0.2 167% n/a 0.0%
2016-03-31 72.00 -1.90 5.70p 28.5 0.7 42% n/a 0.0%
2016-12-31 126.50 -40.10 7.43p 18.4 0.6 30% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 150.28 -77.95 3.06p 31.4 -0.5 -59% 0.00p 0.0%
2018-12-31 174.76 -60.85 3.18p 23.5 5.9 4% 0.00p 0.0%

Newspaper Links

No results found